{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Ledgewood",
      "state": "NJ",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "93093",
      "recalling_firm": "Imprimis NJOF, LLC",
      "address_1": "1705 Route 46 Ste 6B",
      "address_2": "N/A",
      "postal_code": "07852-9720",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Product was distributed to physician's offices nationwide.",
      "recall_number": "D-0043-2024",
      "product_description": "MYDRIATIC-4: Tropicamide - Proparacaine - Phenylephrine - Ketorolac Sterile Ophthalmic Solution Drops 1% - 0.5% - 2.5% - 0.5%, 5mL bottle, Imprimis, NJOF, 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852 (844)-446-6979, NDC:71384-632-05",
      "product_quantity": "6,228 bags + 15,360 boxes",
      "reason_for_recall": "Subpotent: Out of Specification result observed for Ketorolac assay levels, below the 90.0-110.0% of label claim.",
      "recall_initiation_date": "20230920",
      "center_classification_date": "20231013",
      "termination_date": "20250717",
      "report_date": "20231025",
      "code_info": "Lot#s: 22DEC065 (MDU), exp: 09/29/2023; 23JAN024 (MDU), exp: 10/13/2023; 23FEB024 (SDU), exp: 11/09/2023; 23MAR013 (SDU), exp: 12/01/2023; 23MAR033 (SDU), exp: 12/16/2023; 23MAY044 (SDU), exp: 03/23/2024;"
    }
  ]
}